Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated (NYSE: TDG) files a variety of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its aerospace components business, capital structure and governance. This page compiles TransDigm’s SEC filings and pairs them with AI-powered summaries to help readers interpret the information more efficiently.
Investors can use this resource to locate annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically describe TransDigm’s business segments, risk factors, product categories and financial results. For this company, filings often discuss its role as a designer, producer and supplier of highly engineered aircraft components, its organization into segments such as power and control and airframes, and its use of acquisitions and financial leverage as part of its strategy, as reflected in the Polygon description and company disclosures.
Current reports on Form 8-K are particularly important for tracking material events at TransDigm. Recent 8-K filings describe acquisitions such as the Simmonds Precision Products business and a definitive agreement to acquire Stellant Systems, debt offerings and amendments to the company’s credit agreement, special cash dividends funded with new debt and changes in executive leadership and board composition. These documents provide timely details on transactions, financing terms and governance decisions.
This page also offers access to filings related to debt instruments and credit agreements, where TransDigm outlines terms for senior secured notes, senior subordinated notes and term loans, as well as any amendments that reprice or extend these facilities. Where available, insider transaction reports on Form 4 and proxy statements on Schedule 14A can shed light on executive and director share ownership and compensation structures.
Stock Titan’s platform enhances these filings with AI-generated highlights and explanations, helping users quickly identify key sections, understand complex capital structure language and see how new 8-K events connect to prior disclosures. Real-time updates from EDGAR ensure that new TransDigm filings appear promptly, while the AI layer reduces the time needed to parse lengthy documents and track the regulatory record for TDG.
TransDigm Group director Kevin M. Stein, through Fortuna Trust dated June 1, 2018, reported a series of open-market sales of TransDigm common stock on February 2, 2026. The trust sold multiple blocks of shares at average prices ranging from $1,431.4599 to $1,440.4800 per share.
Individual transactions included sales such as 3,093 shares at an average price of $1,433.4578 and 1,497 shares at $1,436.4265. Following these sales, Fortuna Trust was reported as indirectly holding 8,158 TransDigm common shares.
TransDigm Group director-related trust reports option exercises and share sales. On February 2, 2026, Fortuna Trust dated June 1, 2018, an entity associated with director Kevin M. Stein, exercised stock options for 25,000 shares at $341.28 and 23,000 shares at $342.31.
The trust then executed a series of open‑market sales of TransDigm common stock at prices mainly around $1,404–$1,431. Following these transactions, the trust’s indirectly held TransDigm common stock position reported in this filing was 19,233 shares.
TransDigm Group Co-Chief Operating Officer Patrick Joseph Murphy reported an option exercise and share sale. On February 2, 2026, he exercised a stock option for 290 shares of Common Stock at an exercise price of $269.42 per share and acquired these shares.
On the same date, he sold 290 shares of Common Stock at a price of $1,430.1 per share. After these transactions, he beneficially owned 1,055 shares of Common Stock directly and 1,160 stock options directly.
TransDigm Group Incorporated filed a current report to share that it has released a press release covering financial results for its first quarter ended December 27, 2025. The press release is furnished as an exhibit and not treated as filed for securities law liability purposes.
The company is also hosting an investor conference call and live audio webcast on February 3, 2026 at 11:00 a.m. Eastern Time, with related presentation materials available on its investor relations website.
The Fortuna Trust filed a notice of proposed sale for 48,000 shares of TDG common stock through Morgan Stanley Smith Barney, with an aggregate market value of 68,521,920.00 and an approximate sale date of February 2, 2026.
The 48,000 shares were acquired on February 2, 2026 via an exercise of stock options paid in cash. Common shares outstanding were 56,318,584 as of the filing disclosure, a baseline figure that shows the company’s overall equity size.
The filing also lists recent Rule 10b5-1 sales for The Fortuna Trust, including 25,000 common shares sold on January 5, 2026 for gross proceeds of 34,339,836.86 and 17,373 shares sold on January 8, 2026 for 24,448,105.61.
An affiliated shareholder of TransDigm Group has filed to sell 1,160 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/02/2026 on the NYSE, with an aggregate market value of $1,655,946.40. The filing notes that these shares were acquired on 02/02/2026 by exercising stock options granted by the issuer and paid for in cash. The company had 56,318,584 shares outstanding of this class. Over the prior three months, 10b5-1 plan sales for Patrick J. Murphy included three separate 290-share transactions, each generating gross proceeds between about $379,900.00 and $391,807.40.
TransDigm Group (TDG) is asking stockholders to elect ten directors, ratify Ernst & Young as auditor, and approve executive pay at its March 5, 2026 annual meeting. The proxy highlights very strong FY 2025 performance, with net sales of $8.8 billion (up 11%), net income from continuing operations of $2.1 billion (up 21%), and EBITDA As Defined of $4.8 billion (up 14%). Earnings per share from continuing operations rose 25% to $32.08, while adjusted EPS increased 10% to $37.33.
The company returned large amounts of capital through two special dividends totaling about $9.6 billion and $500 million of share repurchases, while deploying over $0.9 billion on acquisitions and refinancing about $6 billion of debt. The filing details a CEO transition to Michael J. Lisman, a largely independent board with a separate chair and lead independent director, extensive stockholder engagement, and an executive compensation program where more than 94% of CEO pay and 97% of other named executive pay is at-risk and largely option-based with rigorous performance hurdles.
TransDigm Group’s Co-Chief Operating Officer Joel Reiss reported an insider transaction involving stock options and common shares on January 15, 2026. He exercised 3,900 stock options at an exercise price of $284.97 per share, receiving the same number of TransDigm common shares. On the same date, he sold common stock in a series of small trades, each reported with an average weighted sale price, at levels ranging from about $1,420 to $1,439 per share. After these transactions, he directly owned 3,600 shares of TransDigm common stock and 35,300 stock options. The footnotes clarify that each reported sale price is a weighted average, with full price breakdowns available to regulators or shareholders on request.
TransDigm Group’s Co-Chief Operating Officer Joel Reiss reported an insider transaction involving stock options and common shares on January 15, 2026. He exercised 3,900 stock options at an exercise price of $284.97 per share, receiving the same number of TransDigm common shares. On the same date, he sold common stock in a series of small trades, each reported with an average weighted sale price, at levels ranging from about $1,420 to $1,439 per share. After these transactions, he directly owned 3,600 shares of TransDigm common stock and 35,300 stock options. The footnotes clarify that each reported sale price is a weighted average, with full price breakdowns available to regulators or shareholders on request.
TransDigm Group director Kevin M. Stein, through Fortuna Trust dated June 1, 2018, reported linked option and share transactions dated January 14, 2026. The trust exercised 7,627 stock options for TransDigm common stock at an exercise price of $342.31 per share, receiving 7,627 shares.
The trust then sold TransDigm common shares in three weighted-average blocks: 2,141 shares at $1,405.6379, 3,964 shares at $1,406.4099, and 1,522 shares at $1,407.3422. After these trades, the trust held 8,158 TransDigm common shares and 43,000 stock options indirectly for the reporting person.
TransDigm Group director Kevin M. Stein, through Fortuna Trust dated June 1, 2018, reported linked option and share transactions dated January 14, 2026. The trust exercised 7,627 stock options for TransDigm common stock at an exercise price of $342.31 per share, receiving 7,627 shares.
The trust then sold TransDigm common shares in three weighted-average blocks: 2,141 shares at $1,405.6379, 3,964 shares at $1,406.4099, and 1,522 shares at $1,407.3422. After these trades, the trust held 8,158 TransDigm common shares and 43,000 stock options indirectly for the reporting person.